Planet Briefing

First published · Last updated

BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians

A journal article published 2026-08-19 reports a modified double-blind Delphi panel of US physicians examining optimization of bridging therapy prior to CAR-T therapy for multiple myeloma. The supplied excerpt included only the publisher and content type and provided no further study details.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
5/10
Geographic reach
5/10
Global importance
3/10
Impact magnitude
3/10
Positivity
7/10
Urgency
2/10

Why it matters

The study addresses optimization of bridging therapy before CAR-T treatment in multiple myeloma.

Location

Sources

Report an issue